#10880 on the rich list of 14,644 insiders
Brian McNulty
10% owner at Telomir Pharmaceuticals; 10% owner at MIRA Pharmaceuticals. Based in Miami, Florida.
$7.5M
in disclosed stock, −$1.1M (−12.96%) today
Market closed. Prices as of Nov 19, 4:00 PM ET
- Rank
- 10880th of 14,644
- Companies held
- 2
- Largest holding
- TELO, 70.3% of total
- Latest SEC filing
- Aug 28, 2024
What the $7.5M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Telomir Pharmaceuticals TELO Common Stock | Through Trust | 5,455,431 | $0.44 | $2.4M | 32.2% | Form 4, Feb 13, 2024 |
| MIRA Pharmaceuticals MIRA Common Stock | Through Trust | 2,540,270 | $0.37 | $935K | 12.5% | Form 4, Aug 28, 2024 |
| Telomir Pharmaceuticals TELO Common Stock | Through Trust | 1,902,659 | $0.44 | $837K | 11.2% | Form 4, Feb 13, 2024 |
| Telomir Pharmaceuticals TELO Common Stock | Indirectly (see filing footnote) | 1,853,659 | $0.44 | $815K | 10.9% | Form 3, Feb 8, 2024 |
| Telomir Pharmaceuticals TELO Common Stock | Through MIRALOGX, LLC | 1,365,646 | $0.44 | $601K | 8.1% | Form 4, Feb 13, 2024 |
| Telomir Pharmaceuticals TELO Common Stock | Through Trust | 1,325,646 | $0.44 | $583K | 7.8% | Form 3, Feb 8, 2024 |
| MIRA Pharmaceuticals MIRA Common Stock | Through Trust Reported jointly by 2 insiders; split evenly | 1,429,659 | $0.37 | $526K | 7.1% | Form 3, Sep 26, 2023 |
| MIRA Pharmaceuticals MIRA Common Stock | Through Trust Reported jointly by 2 insiders; split evenly | 1,370,135 | $0.37 | $504K | 6.8% | Form 4, Dec 11, 2023 |
| MIRA Pharmaceuticals MIRA Common Stock | Indirectly (see filing footnote) | 660,000 | $0.37 | $243K | 3.3% | Form 4, Aug 28, 2024 |
| Telomir Pharmaceuticals TELO Common Stock | Directly | 24,391 | $0.44 | $11K | 0.1% | Form 4, Feb 13, 2024 |
| MIRA Pharmaceuticals MIRA Common Stock | Directly | 10,000 | $0.37 | $4K | 0.0% | Form 4, Aug 28, 2024 |
Share counts are the amounts Brian McNulty reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 10877 | Marc Christopher Thompson Chief Financial Officer, EverCommerce. Denver, CO | $7.5M |
| 10878 | Joseph P. Bergstein, Jr EVP and CFO, PPL. Allentown, PA | $7.5M |
| 10879 | Norbert Nusterer VP & President - Power Systems, Cummins. Columbus, IN | $7.5M |
| 10880 | Brian McNulty 10% owner, Telomir Pharmaceuticals. Miami, FL | $7.5M |
| 10881 | April Rieger Chief Lgl. & Admin Ofc., Sec, nCino. Wilmington, NC | $7.5M |
| 10882 | Richard T. Powers Director, Esquire Financial Holdings. Jericho, NY | $7.5M |
| 10883 | Michael A. Boxer SVP and General Counsel, Thermo Fisher Scientific. Waltham, MA | $7.5M |
Other Telomir Pharmaceuticals insiders
All TELO insiders- Erez Aminov$3.2MCEO and Chairman. #14637 overall
- Craig Eagle$215KDirector. #8350 overall
Questions
How much stock does Brian McNulty own?
Brian McNulty holds $7,457,388 in listed stock based on SEC filings and current prices, mostly Telomir Pharmaceuticals (TELO). That ranks 10880th on the Stock Rich List.
Is this Brian McNulty's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.